Linking Protein Misfolding and Heat Stress: A Common Role for the Kynurenine Pathway

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Kynurenine pathway (KP) of trytophan metabolism is emerging as a key regulator of immune response, neuroinflammation, and neurodegenration. Tryptophan derived metabolites influence multiple processes including excitotoxicty, oxidative stress, mitochondrial dysfunction, and protein aggregation which are underlying mechanisms in major neurological disorders. The dysregulation of the KP leads to an imbalance between neuroprotective metabolites such as kynurenic acid and neurotoxic metabolites including quinolinic acid and 3-hydroxykyrunine, contributing to neuronal dysfunction and disease progression. This imbalance is associated with chronic proteinopathies such as Alzeihmer‘s disease and Parkinson‘s disease, where persistent neuroinflammation and excitotoxicty sustain the activation of KP and subsequent neurodegenaration. Importantly, KP activation is not only limited to chronic conditions but also occurs in acute neurological insults such as heatstroke, where impaired thermoregulation contributes to systemic inflammatory responses, oxidative stress, and disruption of the blood-brain barrier. Consequently, this facilitates the influx of peripheral kyrunine into the brain and its conversion into neuroactive metabolites, linking peripheral immune activation and neuronal injury. These findings highlight KP as mechanistic bridge between acute and chronic neuropathological processes. In addition, the KP involvement in NAD⁺ production links immune activation and cellular energy metabolism, subsequently increasing neuronal vulnerability, particularly under stress. Emerging evidence further support the potential of KP metabolites as diagnostic biomarkers for disease progression and severity, as well as possible therapeutic targets. Targeting key enzymes within the KP may offer novel strategies to reduce neurotoxicity, and restore metabolic balance which subsequently improves clinical outcomes.

Article activity feed